Protocol Specific Research Support

$222,891P30FY2014CANIH

Duke University, Durham NC

Investigators

Linked publications & trials

Paper 39605338 Paper 39416087 Paper 39320053 Paper 39307527 Paper 39253977 Paper 39238136 Paper 39227594 Paper 39176091 Paper 39146842 Paper 39133651 Paper 39083560 Paper 39075068 Paper 39034366 Paper 39014162 Paper 38976158 Paper 38935899 Paper 38886328 Paper 38886323 Paper 38871555 Paper 38860607 Paper 38826146 Paper 38798534 Paper 38788720 Paper 38771177 Paper 38769385 Paper 38759331 Paper 38742743 Paper 38670986 Paper 38650010 Paper 38623754 Paper 38607917 Paper 38569609 Paper 38519039 Paper 38438700 Paper 38380561 Paper 38359680 Paper 38350748 Paper 38325549 Paper 38272925 Paper 38260522 Paper 38260227 Paper 38242440 Paper 38236581 Paper 38226619 Paper 38106038 Paper 38104870 Paper 38104127 Paper 37985794 Paper 37985571 Paper 37922879 Paper 37909039 Paper 37890720 Paper 37884120 Paper 37857141 Paper 37827871 Paper 37772998 Paper 37760589 Paper 37737622 Paper 37697042 Paper 37696029 Paper 37671594 Paper 37655425 Paper 37619838 Paper 37595184 Paper 37588752 Paper 37575220 Paper 37556556 Paper 37543556 Paper 37523502 Paper 37466869 Paper 37460738 Paper 37442696 Paper 37436874 Paper 37350479 Paper 37315312 Paper 37311534 Paper 37307512 Paper 37306774 Paper 37188803 Paper 37182536 Paper 37173865 Paper 37149546 Paper 37009691 Paper 36966348 Paper 36944149 Paper 36931141 Paper 36921295 Paper 36920243 Paper 36917333 Paper 36897758 Paper 36869366 Paper 36853662 Paper 36840621 Paper 36795981 Paper 36755961 Paper 36725084 Paper 36702996 Paper 36701146 Paper 36693221 Paper 36645710

Abstract

There are currently three Clinical Research Nurse FTEs supported by Protocol-Specific Research Support. These nurses support NIH funded PI initiated clinical research programs conducting high volume, and complex, translational early phase clinical research: Neuro-oncology, BMT, Experimental Therapeutics, GYN Oncology, Radiation Oncology, GU Oncology, Thoracic Oncology and Breast and Ovarian Cancer. All of the _studies which qualify for support are reviewed and discussed at the DCCC Executive Committee. After receiving PRMS approval, and review by the Director of the Clinical Trial Shared Resource, the level of support for each trial is assigned. This support is usually distributed to the programs pursuing pilot and Phase I studies for which external funding does not exist or is inadequate. Decisions are also influenced by innovation, feasibility, and priority of the project. These funds support individual clinical research nurses and data managers providing salary support by percent effort. As investigative programs acquire external funding support or as new needs develop for clinical investigators, the funding for these positions is redistributed.

View original record on NIH RePORTER →